2001
DOI: 10.1007/s004240000500
|View full text |Cite
|
Sign up to set email alerts
|

The effects of the inotropic agent EMD 57033 on activation and relaxation kinetics in frog skinned skeletal muscle

Abstract: The effect of the cardiotonic sensitizing drug EMD 57033 was studied in frog skinned skeletal muscle fibres at 12 degrees C to provide a baseline for skeletal muscle studies and for comparison with cardiac fibres. The activation and relaxation of fibres were induced by laser flash photolysis of the caged calcium NP-EGTA, and caged calcium chelator diazo-2 respectively. EMD 57033 (10 microM) slightly increased the rate of relaxation (rate constant k1 changing from 24.0 +/- 2.9 s-1 in control to 28.1 +/- 3.2 s-1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 37 publications
(64 reference statements)
0
2
0
Order By: Relevance
“…EMD increases contraction by enhancing the force produced by individual cross-bridges. 2831 A comparison of cardiomyocytes treated with EMD or those expressing RR + GFP should determine whether myofibril force per se and/or the relative number of force producing cross-bridges is regulated by tensional homeostasis. Prior to adding EMD, initial twitch behavior was assessed.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…EMD increases contraction by enhancing the force produced by individual cross-bridges. 2831 A comparison of cardiomyocytes treated with EMD or those expressing RR + GFP should determine whether myofibril force per se and/or the relative number of force producing cross-bridges is regulated by tensional homeostasis. Prior to adding EMD, initial twitch behavior was assessed.…”
Section: Resultsmentioning
confidence: 99%
“…2227 Alternatively, EMD 57033 (EMD) is an inotropic agent that can be used to increase the average force per actomyosin cross-bridge. 2831 …”
Section: Introductionmentioning
confidence: 99%